Finance

Lists
Why is VTVT up 2,07%?
Dive Deeper
VTVT:NASDAQ
vTv Therapeutics Inc
28,09 $
+2,07%
(+0,57) 1D
15 հոկ, 12:48:22 GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for VTVT...
Open
27,80 $
High
28,87 $
Low
27,45 $
Mkt. cap
111,07 մլն
Avg. vol.
35,07 հզր
Volume
15,94 հզր
52-wk high
44,00 $
52-wk low
19,80 $
EPS
-1,06 $
Beta
0,23
Shares outstanding
3,95 մլն
No. of employees
26
Open
27,80 $
High
28,87 $
Low
27,45 $
Mkt. cap
111,07 մլն
Avg. vol.
35,07 հզր
Volume
15,94 հզր
52-wk high
44,00 $
52-wk low
19,80 $
EPS
-1,06 $
Beta
0,23
Shares outstanding
3,95 մլն
No. of employees
26
News stories
From web sources and news partners
About vTv Therapeutics Inc
CEO-
Employees26
Founded2015
HeadquartersՀայ Փոյնթ, Հյուսիսային Կարոլինա, Միացյալ Նահանգներ
Sector-
Websitevtvtherapeutics.com
Analyst ratings
Based on 5 analysts giving stock ratings to VTVT in the past 3 months
Strong buy
Buy
5
Hold
0
Sell
0
12-month forecast
Based on 5 Wall Street analysts offering 12 month price targets for VTVT in the last 3 months.
Highest
Current 28,09 $
67,00 $ (+138,52%)
Average
56,80 $ (+102,21%)
Lowest
42,00 $ (+49,52%)
Analyst
Recommendation
Action
Price target
Projected
Date
Kambiz Yazdi
BTIG
Buy
Maintained
57,00 $
+102,9%
10/14/2026
Adam Walsh
Roth MKM
Buy
Reiterated
58,00 $
+106,5%
10/06/2026
Patrick Dolezal
LifeSci Capital
Buy
Maintained
60,00 $
+113,6%
10/05/2026
Emily Bodnar
H.C. Wainwright
Buy
Maintained
42,00 $
+49,5%
09/21/2026
Ritu Baral
TD Cowen
Buy
Maintained
67,00 $
+138,5%
08/07/2026
Michael King
Rodman & Renshaw
Buy
Initiated
67,00 $
+138,5%
06/30/2026
James Molloy
Alliance Global Partners
Buy
Reiterated
55,00 $
+95,8%
05/14/2026
Michael DiFiore
Evercore ISI
Buy
Initiated
44,00 $
+56,6%
03/12/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
2025 թ. սեպ
2025 թ. դեկ
2026 թ. մրտ
2026 թ. հնս
Revenue
-
-
36,84 մլն
-
Cost of goods sold
7,02 մլն
3,91 մլն
8,98 մլն
8,77 մլն
Cost of revenue
7,02 մլն
3,91 մլն
8,98 մլն
8,77 մլն
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
3,68 մլն
3,98 մլն
4,60 մլն
5,16 մլն
Operating expense
3,68 մլն
3,98 մլն
4,60 մլն
5,16 մլն
Total operating expenses
10,70 մլն
7,88 մլն
13,58 մլն
13,93 մլն
Operating income
-10,70 մլն
-7,88 մլն
23,26 մլն
-13,93 մլն
Other non operating income
-40,00 հզր
-117,00 հզր
33,00 հզր
64,00 հզր
EBT including unusual items
-10,34 մլն
-7,14 մլն
24,13 մլն
-13,05 մլն
EBT excluding unusual items
-10,34 մլն
-7,14 մլն
24,13 մլն
-13,05 մլն
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-8,70 մլն
-7,14 մլն
24,13 մլն
-13,05 մլն
Net profit margin
-
-
65,51%
-
Earnings per share
-1,08
-0,58
1,65
-1,05
Interest and investment income
399,00 հզր
865,00 հզր
838,00 հզր
812,00 հզր
Interest expense
-5,00 հզր
-1,00 հզր
-
-
Net interest expenses
394,00 հզր
864,00 հզր
838,00 հզր
812,00 հզր
Depreciation and amortization charges
-
-
-
-
EBITDA
-10,70 մլն
-7,88 մլն
23,26 մլն
-13,93 մլն
Gain or loss from assets sale
-
6,00 հզր
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google Apps